Abstract The clinical significance of the tumor‐immune interaction in breast cancer is now established, and tumor‐infiltrating lymphocytes (TILs) have emerged as predictive and prognostic biomarkers for patients with triple‐negative (estrogen receptor, progesterone receptor, and HER2‐negative) breas...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!